OJEMDA

TOVORAFENIB · Day One Biopharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for OJEMDA, covering 2024-04-23 to 2026-02-27. Get the full timeline:

Most recent: New medicine to treat paediatric low-grade glioma